Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sébastien Belliveau
Observed name:
Belliveau, Sébastien
Institution:
Montreal Neurological Institute and Hospital
Observed institutions:
Montreal Neurological Institute and Hospital,
McGill University Health Centre,
McGill University,
Université de Montréal
ORCID:
0000-0002-6652-0899
Observed ORCID:
0000-0002-6652-0899
OpenAlex ID:
A5018296497
Cognition and serotonin in Parkinson's disease
2022
·
Imane Frouni
, Cynthia Kwan
, et al.
·
Progress in brain research
·
34
Combined 5-HT2A and mGlu2 modulation for the treatment of dyskinesia and psychosis in Parkinson's disease
2021
·
Cynthia Kwan
, Imane Frouni
, et al.
·
Neuropharmacology
·
26
Effect of the selective 5-HT2A receptor antagonist EMD-281,014 on l-DOPA-induced abnormal involuntary movements in the 6-OHDA-lesioned rat
2018
·
Imane Frouni
, Cynthia Kwan
, et al.
·
Experimental Brain Research
·
26
Effect of the glycine transporter 1 inhibitor ALX-5407 on dyskinesia, psychosis-like behaviours and parkinsonism in the MPTP-lesioned marmoset
2021
·
Imane Frouni
, Sébastien Belliveau
, et al.
·
European Journal of Pharmacology
·
25
Effect of the mGlu2 positive allosteric modulator CBiPES on dyskinesia, psychosis-like behaviours and parkinsonism in the MPTP-lesioned marmoset
2021
·
Imane Frouni
, Cynthia Kwan
, et al.
·
Journal of Neural Transmission
·
21
Effect of glycine transporter 1 inhibition with bitopertin on parkinsonism and L-DOPA induced dyskinesia in the 6-OHDA-lesioned rat
2022
·
Imane Frouni
, Woojin Kang
, et al.
·
European Journal of Pharmacology
·
18
PDF
Metabotropic glutamate receptors in Parkinson's disease
2022
·
Cynthia Kwan
, Woojin Kang
, et al.
·
International review of neurobiology
·
14
Levodopa-induced Dyskinesia: A Brief Review of the Ongoing Clinical Trials
2021
·
Philippe Huot
, Woojin Kang
, et al.
·
Neurodegenerative Disease Management
·
10
Anti-parkinsonian effect of the mGlu2 positive allosteric modulator LY-487,379 as monotherapy and adjunct to a low L-DOPA dose in the MPTP-lesioned marmoset
2022
·
Imane Frouni
, Cynthia Kwan
, et al.
·
European Journal of Pharmacology
·
9
The Surgical Suite—A Field Laboratory for Sustainability
2022
·
Sébastien Belliveau
, Morgan S. Gold
·
JAMA Surgery
·
8
The anti-dyskinetic effect of the clinic-ready mGluR2 positive allosteric modulator AZD8529 in the 6-OHDA-lesioned rat
2025
·
Judy Shaqfah
, Woojin Kang
, et al.
·
Naunyn-Schmiedeberg s Archives of Pharmacology
·
5
[3H]-NFPS binding to the glycine transporter 1 in the hemi-parkinsonian rat brain
2024
·
Imane Frouni
, Esther Kim
, et al.
·
Experimental Brain Research
·
5
PDF
Reconsidering the Role of Draping in Cystoscopy: An Audit for Sustainability in Urology
2023
·
Sébastien Belliveau
, Fadl A. Hamouche
, et al.
·
European Urology
·
5
Stereological investigation of 5-HT3 receptors in the substantia nigra and dorsal raphe nucleus in the rat
2020
·
Sébastien Belliveau
, Woojin Kang
, et al.
·
Journal of Chemical Neuroanatomy
·
3
Fluoroless Ureteroscopy Under Local Anesthetic Gel: Experience from a Canadian Tertiary Referral Center
2025
·
Tarek Benzouak
, Ahmad Alshammari
, et al.
·
Journal of Endourology
·
2
Effect of mGluR2 and mGluR2/3 activators on parkinsonism in the MPTP-lesioned non-human primate
2024
·
Imane Frouni
, Cynthia Kwan
, et al.
·
Naunyn-Schmiedeberg s Archives of Pharmacology
·
2
Concurrent mGlu2-mGlu4 receptor positive allosteric modulation for L-DOPA-induced treatment-induced complications in the parkinsonian marmoset
2026
·
Imane Frouni
, Cynthia Kwan
, et al.
·
Pharmacology Biochemistry and Behavior
Show more works
View as search
Works count:
18
Citation count:
213
H-index:
9
I10-index:
8
Year
Topic
Type